Andrew C. Karlinski’s Abbott ABT Stock Holding History

Andrew C. Karlinski’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	-$1K	–	257
2022 Q2	$1K	Hold	10	–	–	﹤0.01%	276
2022 Q1	$1K	Hold	10	–	–	﹤0.01%	270
2021 Q4	$1K	Buy	+10	New	+$1.28K	﹤0.01%	182

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Andrew C. Karlinski's ABT Position: Q3 2022 in Review

Andrew C. Karlinski sold out of Abbott (ABT) in Q3 2022, closing a stake of 10 shares — an estimated $1K sold.

Andrew C. Karlinski first reported a position in ABT in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 2,620 funds tracked by Wall St. Rank hold ABT as of Q3 2022.

Andrew C. Karlinski reported no remaining Abbott position as of Q3 2022 after selling out during the quarter.
Andrew C. Karlinski sold 10 Abbott shares in Q3 2022, an estimated $1K.
Andrew C. Karlinski first reported a position in Abbott in Q4 2021 and held it in 3 quarters.
Andrew C. Karlinski's Abbott position peaked at $1K in Q2 2022.
2,620 funds tracked by Wall St. Rank held Abbott as of Q3 2022.

Based on Andrew C. Karlinski's 13F filing for Q3 2022, filed 14 Nov 2022.